NJ A646 | 2018-2019 | Regular Session

Note: Carry Foward to future A1035
Note: Carry Over of previous A1007

Status

Spectrum: Partisan Bill (Democrat 8-0)
Status: Introduced on January 9 2018 - 25% progression, died in committee
Action: 2018-01-09 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Requires insurers to provide coverage for medications and dose-intensive chemotherapy/bone marrow transplants and umbilical cord blood transplants for treatment of sickle cell anemia.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires insurers to provide coverage for medications and dose-intensive chemotherapy/bone marrow transplants and umbilical cord blood transplants for treatment of sickle cell anemia.

Sponsors


History

DateChamberAction
2018-01-09AssemblyIntroduced, Referred to Assembly Financial Institutions and Insurance Committee

Same As/Similar To

A646 (Carry Over) 2018-01-09 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
A1007 (Carry Over) 2017-06-01 - Reported and Referred to Assembly Appropriations Committee

Subjects


New Jersey State Sources


Bill Comments

feedback